Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced Dyskinesias

Ketamine is an FDA-approved drug with a known safety profile. Low-dose subanesthetic intravenous ketamine infusion treatment has led to long-term reduction of treatment-resistant depression and of chronic pain states. We report on low-dose subanesthetic intravenous ketamine infusion treatment in Par...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherman, Scott J., Estevez, Miguel, Magill, Ari B., Falk, Torsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Published online: February, 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899651/
https://www.ncbi.nlm.nih.gov/pubmed/27293405
http://dx.doi.org/10.1159/000444278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899651/
https://www.ncbi.nlm.nih.gov/pubmed/27293405
http://dx.doi.org/10.1159/000444278

Ejemplares similares